secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biofrontera Inc. (BFRI)
CIK:        0001858685
Form:       8-K
Filed at:   2023-12-15T23:59:59+00:00
Accession:  0001493152-23-045074
Event type: other
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biofrontera enters payment addendum with affiliates; schedules ~$7.5M in payments through April 2024
--------------------------------------------------------------------------------

- INC to pay Pharma $2.791M by Dec 20, 2023, reduced by ~$137K owed by Bioscience.
- By Jan 31, 2024, INC owes Pharma ~$1.4-1.6M (DARM00429 remainder) and ~$2.9M under PO#11440.
- By Jan 31, 2024, INC must pay AG invoice AR01207 and Bioscience invoices TAR01584 and TAR01593.
- By Apr 30, 2024, INC pays 2023 purchase price variance and invoices for POs #11272, #11305, #11154.
- Failure to timely pay Licensed Products constitutes material breach, triggering termination without cure period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858685/000149315223045074/0001493152-23-045074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858685/000149315223045074/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-045074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer